# Hikal Ltd (HIKAL)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹205.5
Day Change: +0.4%
52W High: ₹423
52W Low: ₹146.25
Market Cap: ₹2,513 Cr

## Valuation
P/E: 0
P/B: 1.99
EPS: ₹-1.06
Book Value: ₹102.38
Dividend Yield: 0%

## Returns
1Y Return: -17.59%

## Profitability
ROE: 0%
ROCE: 11.16%
Debt/Equity: 0
Revenue Growth: 37.3%
Profit Growth: 68.3%
EBITDA Margin: 18.59%
Operating Margin: 13.16%

## About
Hikal Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Hikal Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Retirement
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- BSE Filing: Announcement under Regulation 30 (LODR)-Retirement

## Access
Current tier: anonymous
More history: Register free to see 13 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:02.224Z
Price History Updated: 2026-05-18T22:58:50.993Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:50.993Z
Quant Updated: 2026-05-18T22:58:50.993Z
Sentiment Updated: 2026-05-18T22:58:50.993Z
Financials Status: current
Financials Updated: 2026-05-19T11:30:34.740Z
Financials Last Attempt: 2026-05-19T11:30:34.740Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹1843.5 Cr
Operating Profit: ₹194.6 Cr (OPM 10.56%)
Net Profit: ₹90.8 Cr
Tax: ₹33 Cr

## Annual P&L History
FY25: Rev ₹1843.5Cr | PAT ₹90.8Cr | OPM 10.56%
FY24: Rev ₹1768.7Cr | PAT ₹69.6Cr | OPM 8.46%
FY23: Rev ₹2004.71Cr | PAT ₹78.38Cr | OPM 7.43%

## Balance Sheet (FY25)
Total Assets: ₹2528.9 Cr
Total Liabilities: ₹1266.6 Cr
Borrowings: ₹764.7 Cr
Cash: ₹13 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Jai Vishwanath Hiremath, Founder & Executive Chairman
- Sameer Jai Hiremath, MD & Vice Chairman
- Kuldeep  Jain, Chief Financial Officer
- Rajasekhar Reddy Chintakindi, Company Secretary & Compliance Officer
- Anish Dilip Swadi, Senior President of Animal Health & Business Transformation

---
Source: rupiya.io/stocks/hikal
Disclaimer: For research and education only. Not investment advice.